Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...
CHS-114, a highly selective Treg depleter, clinical program expanded to include colorectal cancer – – Q3 2025 ending cash, cash equivalents and marketable securities of $191.7 million – – LOQTORZI® ...
SAN FRANCISCO — Glaucoma Research Foundation (GRF) announced the 15th annual Glaucoma 360 event, which unites research, ...
ERS 2025 covered lung cancer treatment advances like robot-assisted bronchoscopy with integrated cone-beam CT (RAB-CBCT) and ...
The College of Engineering and Applied Science at CU Boulder is once again offering a program that allows qualifying PhD applicants to waive their application fees until Nov. 15, 2025. The program is ...
Professor Justin Stebbing was a Professor of Cancer Medicine and Oncology at Imperial College, London (2009-2022), specialising in a range of malignancies, their treatment with immunotherapy (breast, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback